Semliki Forest virus is an efficient and selective vector for gene delivery in infarcted rat heart

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 1, 2004, Pages 137-142

  Loot, Annemarieke E ^a   Henning, Robert H ^a   Deelman, Leo E ^a   Tio, René A ^a   Schoen, Pieter ^a   Wilschut, Jan C ^a   Van Gilst, Wiek H ^a   Roks, Anton J M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adenovirus; Gene therapy; Heart failure; Rat; Semliki Forest virus

Indexed keywords

AMINO ACID DERIVATIVE; BETA GALACTOSIDASE; RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HEART FAILURE; HEART INFARCTION; HISTOCHEMISTRY; KIDNEY; LIVER; LUNG; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMLIKI FOREST ALPHAVIRUS; SPLEEN; TESTIS; VIRUS GENE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; INFLAMMATION; LAC OPERON; MACROPHAGES; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEMLIKI FOREST VIRUS; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFECTION; TRANSGENES;

ADENOVIRIDAE; RABBIT FIBROMA VIRUS; SEMLIKI FOREST VIRUS;

EID: 3142545632     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.04.006     Document Type: Article

References (16)

1. Yla-Herttuala S., Martin J.F. Cardiovascular gene therapy. Lancet. 355:2000;213-222
2. Roks A.J.M., Henning R.H., Buikema H., Pinto Y.M., Kraak M.J.J., Tio R.A., et al. Recombinant Semliki Forest virus as a vector system for fast and selective in vivo gene delivery into balloon-injured rat aorta. Gene Ther. 9:2002;95-101
3. Roks A.J.M., Pinto Y.M., Paul M., Pries F., Stula M., Eschenhagen T., et al. Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus. Cardiovasc Res. 35:1997;498-504
4. Hajjar R.J., Schmidt U., Matsui T., Guerrero J.L., Lee K.H., Gwathmey J.K., et al. Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci USA. 95:1998;5251-5256
5. del Monte F., Williams E., Lebeche D., Schmidt U., Rosenzweig A., Gwathmey J.K., et al. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure. Circulation. 104:2001;1424-1429
6. Buikema H., Monnink S.H., Tio R.A., Crijns H.J., de Zeeuw D., van Gilst W.H. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure. Br J Pharmacol. 130:2000;1999-2007
7. Berglund P., Sjoberg M., Garoff H., Atkins G.J., Sheahan B.J., Liljeström P. Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology. 11:1993;916-920
8. Liljeström P., Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology. 9:1991;1356-1361
9. Haisma H.J., Grill J., Curiel D.T., Hoogeland S., van Beusechem V.W., Pinedo H.M., et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 7:2000;901-904
10. Fazakerley J.K. Pathogenesis of Semliki Forest virus encephalitis. J Neurovirol. 8:(Suppl 2):2002;66-74
11. Perri S., Driver D.A., Gardner J.P., Sherrill S., Belli B.A., Dubensky T.W. Jr, et al. Replicon vectors derived from Sindbis virus and Semliki Forest virus that establish persistent replication in host cells. J Virol. 74:2000;9802-9807
12. Sanders D.A. No false start for novel pseudotyped vectors. Curr Opin Biotechnol. 13:2002;437-442
13. Lundstrom K. Alphaviruses as tools in neurobiology and gene therapy. J Recept Signal Transduct Res. 19:1999;673-686
14. Colmenero P., Berglund P., Kambayashi T., Biberfeld P., Liljestrom P., Jondal M. Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response. Gene Ther. 8:2001;1307-1314
15. Noutsias M., Fechner H., de Jonge H., Wang X., Dekkers D., Houtsmuller A.B., et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation. 104:2001;275-280
16. Alemany R., Curiel D.T. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 8:2001;1347-1353